<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-123504</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">In the Identification of Cardiovascular Risk With the SCORE Model, Could We Recommend Its Calculation Interchangeably With Total Cholesterol or Atherogenic Index? Concordance Between Total Cholesterol and Atherogenic Index in the SCORE Table</dc:title>
<dc:description xml:lang="en">The SCORE table indiscriminately recommends the use of total cholesterol (SCORE-TC) or atherogenic index (SCORE-AI) for calculating cardiovascular (CV) risk. We evaluated reliability and agreement between both methods and the clinical implications for the identification of high CV risk. Observational study (n=8942) in a 40- to 65-year-old population. Spearman's Rho correlation was 0.987 (P&lt;.001), the agreement intraclass correlation coefficient was 0.671 (IC 95% 0.413&#150;0.796; with Bland&#150;Altman's method, the average of the differences between models was 0.74. Kappa index was poor, 0.297 (P&lt;.001) and positive specific agreement was 0.31. Discrepancies fitted individuals with high CV risk with SCORE-TC and not-high with SCORE-AI (4.7%) and 5.8% (n=518) of individuals were classified as high-risk according to SCORE-TC vs. 1.1% (n=95) according to SCORE-AI. Poor agreement was found between SCORE-TC and SCORE-IA for identification of high cardiovascular risk individuals (AU)</dc:description>
<dc:creator>Navarro, Jorge</dc:creator>
<dc:creator>Gil-Guillén, Vicente F</dc:creator>
<dc:creator>Redón, Josep</dc:creator>
<dc:creator>Orozco-Beltrán, Domingo</dc:creator>
<dc:creator>Pallarés, Vicente</dc:creator>
<dc:creator>Pita-Fernández, Salvador</dc:creator>
<dc:creator>Carratalá-Munuera, Concepción</dc:creator>
<dc:creator>Pertusa, Salvador</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La escala SCORE recomienda indistintamente dos métodos para el cálculo del riesgo cardiovascular: uso de colesterol total (CT) o del índice aterogénico (IA). Se evalúa la correlación entre ambos y la concordancia en la identificación del riesgo cardiovascular elevado. Estudio observacional en población de 40-65 años. Se calcula el coeficiente de correlación intraclase (CCI) de acuerdo, el método de Bland-Almand (MBA) y el índice Kappa (IK). El CCI intraclase fue de 0,671 (intervalo del confianza [IC] del 95%, 0,413-0,796; p&lt;0,001); con el MBA, la media de las diferencias fue 0,74. El IK fue 0,297 (p&lt;0,001) y los acuerdos específicos positivos, 0,31. Las discrepancias correspondieron a individuos con riesgo cardiovascular alto con SCORE-CT y no alto con SCORE-IA (4,7%). Presentaban riesgo elevado el 5,8% (n=518) con SCORE-CT y el 1,1% (n=95) con SCORE-IA. Falta acuerdo entre los dos métodos para detectar a los pacientes con alto riesgo (AU)</dc:description>
<dc:source>Rev Esp Cardiol;64(5): 421-423, mayo 2011. ilus, tab</dc:source>
<dc:identifier>ibc-123504</dc:identifier>
<dc:title xml:lang="es">En la identificación del riesgo cardiovascular con el modelo SCORE, ¿se puede recomendar su cálculo indistintamente con colesterol total o índice aterogénico? Concordancia entre el colesterol total y el índice aterogénico en la tabla SCORE</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2834^s22062</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d50504^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>201105</dc:date>
</metadata>
</record>
</ibecs-document>
